Even as weight-loss drugs such as Wegovy and Zepbound explode in popularity, many Americans struggle to afford them.

Analyst Terence Flynn from Morgan Stanley maintained a Buy rating on Eli Lilly & Co (LLY – Research Report) and increased the price target ...

We recently compiled a list of the Billionaire Ken Fisher’s Top 15 Stock Picks Heading Into 2025. In this article, we are ...

More than 7 million Americans struggling with obesity would become eligible for coverage under the proposed change ...

Those prescribed Wegovy or Zepbound or the combination of bupropion and naltrexone also showed a tendency to drink less.

It's uncertain whether the Biden administration proposal to cover obesity drugs in Medicare and Medicaid will survive ...

The outgoing Biden administration is proposing to have popular weight-loss drugs like Wegovy or Zepbound covered by Medicare ...

According to WebMD, "Ozempic and Wegovy are different brand names for the same injectable drug, semaglutide." Wegovy is ...

The market didn't appreciate Amgen 's ( AMGN 1.00%) latest clinical data update, with the biopharma's shares falling more ...

My husband and I have started taking Zepbound for various medical reasons. The medication has significantly and positively ...

Drugs used for weight loss like Wegovy and Zepbound could be covered by Medicare or Medicaid under a new proposal from the Biden administration.